Tuesday, August 4, 2026

Synthetic Biologics Reports Positive Topline Data from Second Phase 2 Clinical Trial of SYN-010 in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)




News Story – QuoteMedia Market Data Solutions




Share: